{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T09:02:51Z","timestamp":1774688571015,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001332","name":"Council for Scientific and Industrial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00616","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T14:35:34Z","timestamp":1555079734000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["EBI-3 Chain of IL-35 Along With TGF-\u03b2 Synergistically Regulate Anti-leishmanial Immunity"],"prefix":"10.3389","volume":"10","author":[{"given":"Mohammad","family":"Asad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdus","family":"Sabur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Shadab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd.","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicky","family":"Didwania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.4049\/jimmunol.1601118","article-title":"Are regulatory T cells defective in type 1 diabetes and can we fix them?","volume":"197","author":"Visperas","year":"2016","journal-title":"J Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/eji.201545843","article-title":"Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB","volume":"46","author":"Toulza","year":"2016","journal-title":"Eur J Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1005924","DOI":"10.1371\/journal.ppat.1005924","article-title":"Follicular regulatory CD8 T cells impair the germinal center response in SIV and ex vivo HIV infection","volume":"12","author":"Miles","year":"2016","journal-title":"PLoS Pathog."},{"key":"B4","first-page":"675","article-title":"Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis","volume":"30","author":"Hasanjani Roushan","year":"2016","journal-title":"J Biol Regul Homeost Agents."},{"key":"B5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ni.2868","article-title":"Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells","volume":"15","author":"Arvey","year":"2014","journal-title":"Nat Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1172\/JCI57175","article-title":"Control of inflammation by integration of environmental cues by regulatory T cells","volume":"123","author":"Chaudhry","year":"2013","journal-title":"J Clin Invest."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0171306","DOI":"10.1371\/journal.pone.0171306","article-title":"Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B","volume":"12","author":"Shadab","year":"2017","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0005035","DOI":"10.1371\/journal.pntd.0005035","article-title":"Noninvasive diagnosis of visceral leishmaniasis: development and evaluation of two urine-based immunoassays for detection of leishmania donovani infection in India","volume":"10","author":"Ejazi","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors."},{"key":"B10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","article-title":"Liposomal elongation factor-1alpha triggers effector CD4 and CD8 T cells for induction of long-lasting protective immunity against visceral leishmaniasis","volume":"9","author":"Sabur","year":"2018","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0004422","DOI":"10.1371\/journal.pntd.0004422","article-title":"Induction of IL-10 and TGFbeta from CD4+CD25+FoxP3+ T cells correlates with parasite load in indian kala-azar patients infected with leishmania donovani","volume":"10","author":"Bhattacharya","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1005398","DOI":"10.1371\/journal.ppat.1005398","article-title":"Blimp-1-dependent IL-10 production by Tr1 cells regulates TNF-mediated tissue pathology","volume":"12","author":"Montes de Oca","year":"2016","journal-title":"PLoS Pathog."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1751-2980.12218","article-title":"IL-35: a potential therapeutic target for controlling hepatitis B virus infection","volume":"16","author":"Xiang","year":"2015","journal-title":"J Dig Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat Immunol."},{"key":"B16","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.65.6.2371-2377.1997","article-title":"Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes","volume":"65","author":"Afrin","year":"1997","journal-title":"Infect Immun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1093\/jac\/dkv254","article-title":"Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis","volume":"70","author":"de Morais-Teixeira","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fimmu.2017.00893","article-title":"Effects of bone marrow mesenchymal stromal cell therapy in experimental cutaneous leishmaniasis in BALB\/c mice induced by Leishmania amazonensis","volume":"8","author":"Pereira","year":"2017","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4049\/jimmunol.181.2.1386","article-title":"Complete cure of experimental visceral leishmaniasis with amphotericin B in stearylamine-bearing cationic liposomes involves down-regulation of IL-10 and favorable T cell responses","volume":"181","author":"Banerjee","year":"2008","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12879-015-0928-6","article-title":"Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME10, a new liposomal amphotericin B","volume":"15","author":"Asad","year":"2015","journal-title":"BMC Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1194\/jlr.D000497","article-title":"The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation","volume":"51","author":"Lin","year":"2010","journal-title":"J Lipid Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1000028","DOI":"10.1371\/journal.ppat.1000028","article-title":"Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis","volume":"4","author":"Stanley","year":"2008","journal-title":"PLoS Pathog."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1002417","DOI":"10.1371\/journal.ppat.1002417","article-title":"Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression","volume":"8","author":"Osorio","year":"2012","journal-title":"PLoS Pathog."},{"key":"B25","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin Immunopathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1004165","DOI":"10.1371\/journal.ppat.1004165","article-title":"Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis","volume":"10","author":"Osorio","year":"2014","journal-title":"PLoS Pathog."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1002827","DOI":"10.1371\/journal.ppat.1002827","article-title":"IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c(+) cell populations during visceral leishmaniasis","volume":"8","author":"Owens","year":"2012","journal-title":"PLoS Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0163604","DOI":"10.1371\/journal.pone.0163604","article-title":"CD4+ recent thymic emigrants are recruited into granulomas during leishmania donovani infection but have limited capacity for cytokine production","volume":"11","author":"Moore","year":"2016","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1128\/CDLI.7.2.233-240.2000","article-title":"Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis","volume":"7","author":"Mukhopadhyay","year":"2000","journal-title":"Clin Diagn Lab Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/1471-2180-10-181","article-title":"Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis","volume":"10","author":"Ravindran","year":"2010","journal-title":"BMC Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.parint.2005.02.005","article-title":"Function of CD8+ T lymphocytes in a self-curing mouse model of visceral leishmaniasis","volume":"54","author":"Tsagozis","year":"2005","journal-title":"Parasitol Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.4049\/jimmunol.1202535","article-title":"Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/ijc.31382","article-title":"IL-35, a hallmark of immune-regulation in cancer progression, chronic infections and inflammatory diseases","volume":"143","author":"Teymouri","year":"2018","journal-title":"Int J Cancer."},{"key":"B34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.4049\/jimmunol.180.6.4090","article-title":"IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL\/6 mice","volume":"180","author":"Anderson","year":"2008","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1002\/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q","article-title":"The TGF-beta response to Leishmania chagasi in the absence of IL-12","volume":"32","author":"Wilson","year":"2002","journal-title":"Eur J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2567","DOI":"10.1371\/journal.pntd.0002567","article-title":"Impairment of T cell function in parasitic infections","volume":"8","author":"Rodrigues","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1038\/s41598-018-21891-z","article-title":"HIF-1alpha hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis","volume":"8","author":"Hammami","year":"2018","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bjid.2017.04.007","article-title":"Leishmania donovani infection activates Toll-like receptor 2, 4 expressions and Transforming growth factor-beta mediated apoptosis in renal tissues","volume":"21","author":"Kumar","year":"2017","journal-title":"Braz J Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e0004415","DOI":"10.1371\/journal.pntd.0004415","article-title":"Combined immune therapy for the treatment of visceral leishmaniasis","volume":"10","author":"Faleiro","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B42","first-page":"489","article-title":"Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide","volume":"47","author":"Bhattacharjee","year":"2009","journal-title":"Indian J Exp Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.immuni.2016.01.013","article-title":"Interleukin-35 limits anti-tumor immunity","volume":"44","author":"Turnis","year":"2016","journal-title":"Immunity."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","journal-title":"Eur J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1128\/IAI.73.7.3903-3911.2005","article-title":"Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis","volume":"73","author":"Murray","year":"2005","journal-title":"Infect Immun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1128\/IAI.01468-12","article-title":"Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver","volume":"81","author":"Murray","year":"2013","journal-title":"Infect Immun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"ftv063","DOI":"10.1093\/femspd\/ftv063","article-title":"Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB\/c mice: critical role of IRF1","volume":"73","author":"Chowdhury","year":"2015","journal-title":"Pathog Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1128\/IAI.01739-07","article-title":"Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection","volume":"77","author":"Bhowmick","year":"2009","journal-title":"Infect Immun."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1128\/IAI.66.3.1233-1236.1998","article-title":"Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis","volume":"66","author":"Rodrigues","year":"1998","journal-title":"Infect Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.16943\/ptinsa\/2014\/v80i2\/55105","article-title":"Dynamicity of immune regulation during visceral leishmaniasis","volume":"80","author":"Asad","year":"2014","journal-title":"Proc Indian Natl Sci Acad."}],"updated-by":[{"DOI":"10.3389\/fimmu.2019.02409","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,6]],"date-time":"2020-12-06T06:41:22Z","timestamp":1607236882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2019.00616"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00616","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2019.02409","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"article-number":"616"}}